Abstract:P-glycoprotein (P-gp) actively transports a wide variety of chemically diverse compounds out of cells. It is highly associated with the ADMET properties of drugs and drug candidates and, moreover, plays a major role in the multidrug resistance (MDR) phenomenon, which leads to the failure of chemotherapy in cancer treatments. Therefore, the recognition of potential P-gp substrates at the early stages of the drug discovery process is quite important. Here, we compiled an extensive data set containing 423 P-gp substrates and 399 nonsubstrates, which is the largest P-gp substrate/nonsubstrate data set yet published. Comparison of the distributions of eight important physicochemical properties for the substrates and nonsubstrates reveals that molecular weight and molecular solubility are the informative attributes differentiating P-gp substrates from nonsubstrates. Examination of the distributions of eight physicochemical properties for 735 P-gp inhibitors and 423 substrates gives the fact that inhibitors are significantly more hydrophobic than substrates while substrates tend to have more H-bond donors than inhibitors. Then, the classification models based on simple molecular properties, topological descriptors, and molecular fingerprints were developed using the naive Bayesian classification technique. The best naive Bayesian classifier yields a Matthews correlation coefficient of 0.824 and a prediction accuracy of 91.2% for the training set from a 5-fold cross-validation procedure, and a Matthews correlation coefficient of 0.667 and a prediction accuracy of 83.5% for the test set containing 200 molecules. Analysis of the important structural fragments given by the Bayesian classifier shows that the essential H-bond acceptors arranged in distinct spatial patterns and flexibility are quite essential for P-gp substrate-likeness, which affords a deeper understanding on the molecular basis of substrate/P-gp interaction. Finally, the reasons for mispredictions were discussed. It turns out that the presented classifier could be used as a reliable virtual screening tool for identifying potential substrates of P-gp.

Prediction and characterization of P-glycoprotein substrates potentially bound to different sites by emerging chemical pattern and hierarchical cluster analysis

Emerging chemical patterns applied to prediction of P-glycoprotein inhibitors

Admet Evaluation in Drug Discovery. 13. Development of in Silico Prediction Models for P-Glycoprotein Substrates

ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques.

Prediction of P-Glycoprotein Substrates by a Support Vector Machine Approach

Combined Qsar and Molecule Docking Studies on Predicting P-Glycoprotein Inhibitors

Identifying P-Glycoprotein Substrates Using a Support Vector Machine Optimized by a Particle Swarm.

Classification of substrates and inhibitors of P-glycoprotein using unsupervised machine learning approach.

Study of Concerted Mechanism Between P-glycoprotein and Cytochrome P4503A4 by 3D-Pharmacophore Modeling

In Silico Pharmacophore Models to Predict Endogenous Substrates for Human Multidrug Resistance-Associated Proteins

Development of Simple and Accurate in Silico Ligand-Based Models for Predicting ABCG2 Inhibition

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

An Energetically Favorable Ligand Entrance Gate of a Multidrug Transporter Revealed by Partial Nudged Elastic Band Simulations.

Consensus screening for a challenging target: the quest for P-glycoprotein inhibitors

Simultaneous Binding Mechanism of Multiple Substrates for Multidrug Resistance Transporter P-glycoprotein.

Computational Insights Into Allosteric Conformational Modulation Of P-Glycoprotein By Substrate And Inhibitor Binding

Rapid identification of P-glycoprotein substrates and inhibitors

Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

Prediction of Sites of Metabolism of CYP3A4 Substrates Utilizing Docking-Derived Geometric Features

ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning